Crypto Market Cap, BTC/USD, ETH/USD, USDT/USD, XRP/USD, Bitcoin
Apple, Advanced Micro Devices Inc, Amazon Com Inc, TESLA INC, NETFLIX INC, Facebook Inc
S&P 500, Nasdaq 100, Dow 30, Russell 2000, U.S. Dollar Index, Bitcoin Index
US 10Y, Euro Bund, Germany 10Y, Japan 10Y Yield, UK 10Y, India 10Y
Notice how many times price has been rejected from the pink line -- and also notice how price is now above that resistance! EASY 100% gains from this point onward!
NASDAQ:GTHX Possible Scenario: SHORT Evidence: Overbought RSI. Bearish Divergence * It's trading higher without any specific news, will drop soon. It's my opinion and could be wrong 100%
Insider buys: On Nov 18, 2020, Director, Glenn P Muir, purchased 50,000 shares in G1 Therapeutics (GTHX) for $675,000. It has a Market Cap of 544.056M G1 Therapeutics is a a clinical-stage biopharmaceutical company which engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with...
Not sure about this one. Volatile as hell and weak (ish) buy signals. Analysts going mad for it tho... Any thoughts..?
Earnings/News Co's lead cancer therapy, trilaciclib, gets FDA's "breakthrough therapy" status, which is meant to speed up review of drugs that treat life-threatening conditions GTHX says it will present new data on three of its drugs, including trilaciclib, at an upcoming conference in September FDA's move is a recognition that clinical data presented...
paints quite a different picture. The ABC is not quite complete yet. There is a potential drop from $21 to $12.
GTHX: g1 therapeutics inc 2018-03-05 06:00:22 Detected possible positive results in drug trial